The relationship between FXR activation and reduction in biomarkers associated with inflammation is becoming more apparent with the growing body of research, which highlights the potential anti-inflammatory benefits of bile acids in pathologies associated with chronic inflammation, such as diabetes mellitus. The gene discussed is NR1H4; the disease is diabetes mellitus.